X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ALEMBIC PHARMA FDC LTD./
ALEMBIC PHARMA
 
P/E (TTM) x 29.0 28.6 101.5% View Chart
P/BV x 6.0 6.5 92.8% View Chart
Dividend Yield % 0.8 0.7 108.3%  

Financials

 FDC LTD.   ALEMBIC PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ALEMBIC PHARMA
Mar-16
FDC LTD./
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs144792 18.1%   
Low Rs79443 17.8%   
Sales per share (Unadj.) Rs47.6167.0 28.5%  
Earnings per share (Unadj.) Rs7.638.2 19.9%  
Cash flow per share (Unadj.) Rs9.042.0 21.5%  
Dividends per share (Unadj.) Rs2.254.00 56.3%  
Dividend yield (eoy) %2.00.6 312.1%  
Book value per share (Unadj.) Rs47.584.9 56.0%  
Shares outstanding (eoy) m177.83188.52 94.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.7 63.3%   
Avg P/E ratio x14.616.2 90.4%  
P/CF ratio (eoy) x12.314.7 84.0%  
Price / Book Value ratio x2.37.3 32.2%  
Dividend payout %29.610.5 282.1%   
Avg Mkt Cap Rs m19,784116,383 17.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2214,214 29.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,45931,487 26.9%  
Other income Rs m39455 714.2%   
Total revenues Rs m8,85231,542 28.1%   
Gross profit Rs m2,07010,060 20.6%  
Depreciation Rs m249722 34.5%   
Interest Rs m3137 84.3%   
Profit before tax Rs m2,1849,356 23.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-225-2 14,993.3%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6062,160 28.0%   
Profit after tax Rs m1,3537,194 18.8%  
Gross profit margin %24.531.9 76.6%  
Effective tax rate %27.723.1 120.1%   
Net profit margin %16.022.8 70.0%  
BALANCE SHEET DATA
Current assets Rs m4,35515,066 28.9%   
Current liabilities Rs m1,7927,674 23.3%   
Net working cap to sales %30.323.5 129.1%  
Current ratio x2.42.0 123.8%  
Inventory Days Days4467 66.4%  
Debtors Days Days2541 60.7%  
Net fixed assets Rs m3,0258,237 36.7%   
Share capital Rs m179377 47.4%   
"Free" reserves Rs m8,24315,416 53.5%   
Net worth Rs m8,45316,005 52.8%   
Long term debt Rs m110-   
Total assets Rs m10,55724,594 42.9%  
Interest coverage x71.4255.2 28.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.3 62.6%   
Return on assets %13.129.4 44.6%  
Return on equity %16.044.9 35.6%  
Return on capital %23.558.7 40.1%  
Exports to sales %13.355.7 23.9%   
Imports to sales %3.310.4 32.1%   
Exports (fob) Rs m1,12617,551 6.4%   
Imports (cif) Rs m2833,283 8.6%   
Fx inflow Rs m1,14617,811 6.4%   
Fx outflow Rs m3555,318 6.7%   
Net fx Rs m79112,493 6.3%   
CASH FLOW
From Operations Rs m1,4859,304 16.0%  
From Investments Rs m-620-3,105 20.0%  
From Financial Activity Rs m-753-1,959 38.4%  
Net Cashflow Rs m1134,240 2.7%  

Share Holding

Indian Promoters % 68.9 74.1 93.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 2.9 162.1%  
FIIs % 7.5 9.1 82.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 13.9 136.7%  
Shareholders   23,730 49,328 48.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   CADILA HEALTHCARE  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  TORRENT PHARMA  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of PNB Fraud, Rising Troubles at PSBs, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 236 points and the NSE Nifty closed down by 74 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 19, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS